StreetInsider.com News Articles

Form 425 Translational Developmen Filed by: Prologium Holding Inc.

Tue, 28 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260728/26827047.html

Form 425 Translational Developmen Filed by: Prologium Holding Inc.

Tue, 28 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260728/26827047.html

Form 425 Translational Developmen Filed by: Prologium Holding Inc.

Tue, 28 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260728/26827047.html

ProLogium secures $50M investment ahead of SPAC merger

Tue, 28 Jul 2026 09:01:13 -0400

ProLogium Holding Inc. and Translational Development Acquisition Corp. (Nasdaq: TDAC) announced a $50 million capital commitment from existing ProLogium shareholders to support their planned business combination that would take ProLogium public.

The investment is based on a pre-money valuation of ProLogium of approximately $3.8 billion and forms part of the previously announced target financing tied to the transaction.

According to a press release, ProLogium plans to use the proceeds to advance the scale-up of its lithium ceramic battery production and support construction of its planned gigafactory in Dunkirk, France. That facility broke ground in February 2026 and is designed to reach a

ProLogium secures $50M investment ahead of SPAC merger

Tue, 28 Jul 2026 09:01:13 -0400

The investment is based on a pre-money valuation of ProLogium of approximately $3.8 billion and forms part of the previously announced target financing tied to the transaction.

ProLogium secures $50M investment ahead of SPAC merger

Tue, 28 Jul 2026 09:01:13 -0400

The investment is based on a pre-money valuation of ProLogium of approximately $3.8 billion and forms part of the previously announced target financing tied to the transaction.

ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

Tue, 28 Jul 2026 09:00:00 -0400

Investment consists of $50 million of committed capital from existing investors of ProLogium at the previously announced pre-money valuation of ProLogium of approximately $3.8 billion
Proceeds form part of the previously announced target financing to support ProLogium’s proposed business combination with TDAC
ProLogium expects to use proceeds to support the continued scale-up of its next-generation lithium ceramic battery production and advance construction of its planned gigafactory in Dunkirk, France, supported by its subsidy package of up to €1.375 billion from the Government of the French Republic

TAIPEI, Taiwan and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) --

ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

Tue, 28 Jul 2026 09:00:00 -0400

Investment consists of $50 million of committed capital from existing investors of ProLogium at the previously announced pre-money valuation of ProLogium of approximately $3.8 billion
Proceeds form part of the previously announced target financing to support ProLogium’s proposed business combination with TDAC
ProLogium expects to use proceeds to support the continued scale-up of its next-generation lithium ceramic battery production and advance construction of its planned gigafactory in Dunkirk, France, supported by its subsidy package of up to €1.375 billion from the Government of the French Republic

TAIPEI, Taiwan and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) --

Form 425 Translational Developmen Filed by: Translational Development Acquisition Corp.

Mon, 27 Jul 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260727/26819635.html

Form 425 Translational Developmen Filed by: Translational Development Acquisition Corp.

Mon, 27 Jul 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260727/26819635.html

Form 425 Translational Developmen Filed by: Translational Development Acquisition Corp.

Mon, 27 Jul 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260727/26819635.html

Form 8-K Translational Developmen For: Jul 27

Mon, 27 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260727/26819585.html

Form 8-K Translational Developmen For: Jul 27

Mon, 27 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260727/26819585.html

Form 8-K Translational Developmen For: Jul 27

Mon, 27 Jul 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260727/26819585.html

Form SCHEDULE 13G/A Translational Developmen Filed by: WOLVERINE ASSET MANAGEMENT LLC

Thu, 16 Jul 2026 13:39:00 -0400

si-local-file:///var/storage/secattach/20260716/26778927.html

Form SCHEDULE 13G/A Translational Developmen Filed by: WOLVERINE ASSET MANAGEMENT LLC

Thu, 16 Jul 2026 13:39:00 -0400

si-local-file:///var/storage/secattach/20260716/26778927.html

Form SCHEDULE 13G/A Translational Developmen Filed by: WOLVERINE ASSET MANAGEMENT LLC

Thu, 16 Jul 2026 13:39:00 -0400

si-local-file:///var/storage/secattach/20260716/26778927.html

Form 8-K Translational Developmen For: Jul 06

Wed, 08 Jul 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260708/26744642.html

Form 8-K Translational Developmen For: Jul 06

Wed, 08 Jul 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260708/26744642.html

Form 8-K Translational Developmen For: Jul 06

Wed, 08 Jul 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260708/26744642.html

ProLogium files F-4 with SEC ahead of planned SPAC merger

Mon, 06 Jul 2026 09:57:15 -0400

Translational Development Acquisition Company (NYSE: TDAC) announced that ProLogium has filed an initial Form F-4 registration statement with the Securities and Exchange Commission, advancing the companies toward a de-SPAC merger transaction that was announced on May 27, 2026.